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Abstract 1 
Bacteria export proteins across membranes using a range of transport 2 
machineries. Type VII secretion systems (T7SSs), originally described in 3 
mycobacteria, are now known to be widespread across diverse bacterial 4 
phyla. Recent studies have characterized secretion components and 5 
mechanisms of type VII secretion in pathogenic and environmental bacteria. A 6 
variety of functions have been attributed to T7SS substrates, including 7 
interactions with eukaryotes and with other bacteria. Here, we evaluate the 8 
growing body of knowledge on T7SSs, with focus on the non-mycobacterial 9 
systems, reviewing their phylogenetic distribution, structure and function in 10 
diverse settings. 11 
  12 
 3 
Type VII Secretion: Discovery in Mycobacteria 1 
Bacteria possess a range of transport mechanisms that export proteins across 2 
the cell envelope. Bacterial secretion systems that mediate protein 3 
translocation across the bi-layered Gram-negative cell envelope have been 4 
classified into six numbered types, Types I to VI [1]. In monoderm Gram-5 
positive bacteria, the Sec, Tat and flagellar secretion systems were initially 6 
thought to account for all protein export, until the discovery of a new 7 
specialised secretion system, ESX-1, in Mycobacterium tuberculosis. This 8 
system first generated attention because it is responsible for the export of an 9 
abundant immunogenic protein, ESAT-6 (early secreted antigen target 6; also 10 
called EsxA) [2-4]. Additional substrates and components of ESX-1 have 11 
since been identified and characterized, including multiple EccC family 12 
ATPases [5], leading to the development of models that incorporate structure, 13 
function and regulation of this complex secretion apparatus [6, 7]. In addition 14 
to ESX-1, M. tuberculosis possesses paralogous ESX systems, ESX-2 to 15 
ESX-5, which have broadly similar features [5, 8]. The ESX-1 system plays an 16 
important role in M. tuberculosis virulence and a number of ESX-1 effectors 17 
interfere in host cellular and immune functions, primarily by modulating host 18 
macrophage and T cell responses [9]. However, the precise evolutionary and 19 
functional context for these activities remains uncertain.  20 
 21 
The numerical nomenclature for secretion systems was initially restricted to 22 
Gram-negative bacteria. However, as it became clear that the mycobacterial 23 
cell envelope also possessed a diderm structure analogous to the Gram-24 
negative cell wall, the nomenclature was extended to incorporate the 25 
 4 
mycobacterial ESX systems, which were renamed type VII secretion systems 1 
(T7SSs) [10].  2 
 3 
Shortly after the discovery of type VII secretion in mycobacteria, genome 4 
analyses suggested the existence of similar systems in diverse groups of 5 
Gram-positive bacteria [11]. However, these T7SSs appeared to be less 6 
complex than their mycobacterial counterparts, each with just a single 7 
ATPase from the EccC family that contains several FtsK/SpoIIIE domains, 8 
together with a handful of secretion substrates. These simpler systems were 9 
given the name type VIIb secretion systems to distinguish them from their 10 
more complex mycobacterial relatives [12, 13]. Mycobacterial type VII 11 
secretion has been reviewed extensively elsewhere [5, 13-15]. Here, we will 12 
focus instead on type VIIb secretion systems, summarising new 13 
developments in their phylogenetic distribution, structure and function. 14 
 15 
Type VII Secretion Occurs Widely Outside the Mycobacteria 16 
Analysis of the M. tuberculosis genome showed that EsxA is a member  of a 17 
family of paralogous proteins [16]. A small-scale comparative genome 18 
analysis revealed that gene clusters encoding esxA homologues were also 19 
found in several close relatives of M. tuberculosis within the Actinobacteria, 20 
including Corynebacterium diphtheriae and Streptomyces coelicolor [8]. 21 
Predicted proteins representing EsxA homologues were subsequently 22 
identified in several members of the other predominantly Gram-positive 23 
phylum, the Firmicutes, including bacterial species with roles as pathogens, 24 
model organisms or in biotechnology, such as Staphylococcus aureus, 25 
 5 
Bacillus anthracis, Streptococcus agalactiae, Bacillus subtilis (Figure 1), 1 
Rhodococcus equi, and Clostridium acetobutylicum [11, 17-20]. As sequence 2 
conservation is centered on a WXG motif, and most of these EsxA homologs 3 
were around 100 amino acids in length, the term “WXG100 proteins” was 4 
coined to describe the family. In the Firmicutes, genes for WXG100 proteins 5 
were located in gene clusters that also encoded a conserved ATPase, which 6 
contained several FtsK/SpoIIIE domains and which was predicted to power 7 
type VII secretion.  8 
 9 
In a later study, Jang et al. showed that an uncharacterized protein, Hp0062, 10 
from the Gram-negative pathogen, Helicobacter pylori, shared unexpected but 11 
unequivocal structural homology with WXG100 proteins from M. tuberculosis 12 
and S. aureus [21]. Subsequently, Sutcliffe examined the phylogenetic 13 
distribution of the WXG100 proteins and reported their occurrence in four 14 
phyla with a Gram-negative or diderm cell architecture, the Proteobacteria, 15 
the Cyanobacteria, Lentisphaerae, Verrucomicrobiae as well as in the 16 
monoderm phylum, Chloroflexi [22]. 17 
 18 
An up-to-date phylogenetic survey (Table 1) reveals the presence of WXG100 19 
proteins in several additional bacterial phyla or sub-phyla (Table 1), including 20 
all five sub-divisions of the Proteobacteria (incorporating several important 21 
pathogenic species including Pseudomonas aeruginosa, Vibrio cholerae and 22 
Stenotrophomonas maltophilia) together with the Fusobacteria, the 23 
Planctomycetes and the Tenericutes. 24 
 25 
 6 
Scrutiny of the entry for the WXG100 domain in the PFAM database 1 
(PF06013) provides a ready guide to the various protein architectures that 2 
house this feature (http://pfam.xfam.org/family/PF06013#tabview=tab1). In the 3 
majority (>96%) of cases, this domain occurs in a simple one-domain 4 
architecture, where the WXG100 domain occupies the entire protein. 5 
However, there are now several examples of this domain within a multi-6 
domain protein, typically linked to an enzymatic domain. Most of these 7 
domains are linked to toxin-antitoxin systems (e.g. PT-TG, Toxin-deaminase, 8 
Colicin-DNase, Tox-HNH-EHHH, DUF2974, CHAP, Ntox44, and Ntox28). In 9 
many cases these domains appear to be important participants in conflicts 10 
between the cells that carry them and other cells.  However, some of these 11 
enzymatic domains may play other roles: for example, the lytic 12 
transglycosylase activity of the PT-TG domain cleaves the cell wall 13 
peptidoglycan making space for the assembly of membrane spanning 14 
structures such as secretion systems and flagella [23]. Colicins and pyocins 15 
[24, 25] contain HNH domains with DNase activities, acting specifically 16 
against Escherichia coli and P. aeruginosa cells respectively, eliciting cell 17 
death through random cleavage of chromosomal DNA [26].The targets of 18 
these systems are diverse including action against eukaryotic hosts, against 19 
other bacterial species and against members of the same bacterial species 20 
fighting for a common niche [25, 27-31]. Additional evidence for a link 21 
between T7SSs and toxin-antitoxin systems comes from a wide-ranging 22 
bioinformatics survey that reports fusions of WXG100 domains to toxin 23 
domains and the presence of toxin and immunity proteins in many T7SS gene 24 
clusters [27]. 25 
 7 
 1 
Interestingly, a recent analysis from Das et al. [32] revealed an association of 2 
the putative EsxA homologue, HP_0062 [21],  with an FtsK/SpoIIIE ATPase in 3 
at least 21 complete H. pylori genomes. Besides the typical WXG proteins, 4 
the cluster contains HP_0063, which has an HNH/colicin domain [27], as well 5 
as a protein (HP_0064) that belongs to the SUKH superfamily prototyped by 6 
the Saccharomyces cerevisiae protein Smi1/Knr4, which is responsible for 7 
conferring resistance to the killer toxin produced by competing yeast (Figure 8 
1). Nevertheless, experimental evidence is required to corroborate the 9 
suggestions of putative T7SS from H. pylori and other Gram-negative 10 
bacteria.  11 
 12 
The WXG100 proteins have been classified into three subfamilies based on 13 
their similarity to the heterodimeric mycobacterial proteins EsxA (ESAT-6) or 14 
EsxB (CFP-10), which are encoded in bicistronic operons [17, 33], or to the 15 
homodimeric non-mycobacterial type VIIb effector EsxA, which is typically 16 
encoded in a monocistronic operon [17, 34, 35]. A key conserved feature 17 
across the WXG100 protein families is a C-terminus consensus sequence 18 
HxxxD/ExxhxxxH, where ‘H’ is a highly conserved hydrophobic residue and ‘h’ 19 
is a less conserved hydrophobic residue [17]. In mycobacteria, a YxxxD/E 20 
motif is the C-terminal secretion signal required for general targeting of type 21 
VII substrates, including WXG100 proteins, and for the modulation of 22 
substrate binding and activity of a central ATPase [6, 36, 37]. Similarly, the C-23 
terminal tail is important for secretion of type VIIb effectors in S. aureus and B. 24 
subtilis [35, 38, 39]. In B. subtilis, substrate export requires a composite 25 
 8 
secretion signal formed by both the WXG100 and C-terminal motifs, each 1 
contributed by individual subunits of the substrate dimer [35]. Given the 2 
conservation of these motifs across type VII substrates, they likely play a 3 
crucial role in controlling type VIIb secretion [6]. 4 
 5 
Despite the now-abundant evidence from sequence-based analyses that type 6 
VII secretion occurs outside the mycobacteria, type VIIb secretion systems 7 
have been analysed experimentally only in a handful of bacterial genera, 8 
including Staphylococcus and Bacillus.  9 
 10 
The Staphylococcus aureus T7SS 11 
Among the type VIIb secretion systems, the best characterized is that of the 12 
opportunistic human pathogen, S. aureus. The system, termed Ess (for 13 
ESAT-6 secretion system), is required for virulence in murine abscess, 14 
pneumonia and skin infection models [40-42] and is linked to the 15 
establishment of persistent infection [40, 43]. The ess genes showed high 16 
levels of upregulation during chronic S. aureus infection in cystic fibrosis 17 
patients [44], suggesting a similar role in persistent infection in humans.  18 
 19 
The Ess machinery comprises six core components [40, 41] (Figure 2), 20 
including one extracellular protein, one cytoplasmic protein and four 21 
membrane proteins. The most abundant component is EsxA, a secreted 22 
WXG100 protein that forms a homodimer [34, 41, 45]. EsxA displays a high 23 
degree of sequence conservation across S. aureus strains [45] and is 24 
required for the secretion of other Ess substrates [38, 40, 41], strongly 25 
 9 
implicating it as a core extracellular component. The second soluble protein is 1 
EsaB, which harbours a ubiquitin-like fold [46]  and appears to regulate the 2 
Ess machinery [41, 43].  3 
 4 
The four key membrane proteins include EssA, EssB, EssC and EsaA. While 5 
EssA is required for substrate secretion, the requirement for EsaA appears to 6 
be strain-dependent [41, 43]. X-ray structures are available for soluble 7 
domains of EssB [47, 48] and EssC [6, 49]. EssB, has a cytoplasmic domain 8 
with a pseudokinase fold, but it lacks ATP-binding signature motifs and is 9 
unable to bind ATP-analogues [47].  10 
 11 
EssC, the predicted FtsK/SpoIIIE-like motor protein, contains three C-terminal 12 
P-loop ATPase domains (D1-D3). Deletion analysis suggests that all three are 13 
essential for secretion [49]. Similarly, a transposon insertion in the N-terminal 14 
region of D1 abolishes EsxA and EsxB secretion, but curiously, transposon 15 
mutants with insertions in the last two domains remain capable of secretion 16 
[40]. The reason for this discrepancy is not clear.  17 
 18 
Proteins of the FtsK/SpoIIIE family, including EccC1, are known to form 19 
hexamers [6]. Although no structures have yet been obtained for the S. 20 
aureus EssC ATPase domains, homology modelling has provided fresh 21 
insights into this phenomenon. X-ray structures of the C-terminal P-loop 22 
domains (D2 and D3) have been obtained from the EccC homologue from 23 
Geobacillus thermodenitrificans. These structures show that D2 has ATP 24 
bound whereas D3 exists in two conformations; ATP binding is occluded in 25 
 10 
one of these [6, 49]. Modelling the X-ray structure of the C-terminal domains 1 
of the G. thermodentrificans EssC on to the known hexameric structure of 2 
FtsK suggests that EssC possesses an internal pore (diameter~30 Å) wide 3 
enough to accommodate EsxA dimers [49].  4 
 5 
EssC proteins from type VIIb secretion systems have tandem forkhead-6 
associated (FHA) domains at their N-termini, unlike the related mycobacterial 7 
EccC proteins [49, 50]. FHA domains typically bind phospho-threonine 8 
peptides and are known to mediate phosphorylation-dependent protein–9 
protein interactions [51]. However, no function has yet been assigned to the 10 
FHA domains in EssC, apart from contributing to overall protein stability [49]. 11 
In vivo crosslinking analysis indicated that Ess membrane proteins homo-12 
multimerise [52] Although multimerisation of Thermomonospora curvata EccC 13 
is controlled by substrate interactions, EssC multimerisation was observed in 14 
a strain of S. aureus lacking core Ess components and substrates.[52]. Thus, 15 
even if these ATPases show significant sequence homology, there appear to 16 
be differences in the control of their assembly and activity.   17 
 18 
Ess secretion has been studied in several S. aureus strains, including 19 
Newman [40, 43, 53], USA300 [38], RN6390 and COL [41]. Genomic analysis 20 
shows that the organisation of the ess loci in these strains is highly similar 21 
although there is some transcriptional heterogeneity between the strains [41]. 22 
Transcription of esxA, the first gene of the cluster, is under control of the 23 
alternative sigma factor B [54]. EsxA is required for bacterial virulence and 24 
was recently shown to suppress host cell apoptosis during intracellular 25 
 11 
infection [39, 41, 43]. In addition to EsxA, four substrates of the secretion 1 
system have been described: EsxB, EsxC, EsxD and EsaD.  2 
 3 
EsaD is the only substrate to which a function has been assigned. Initial 4 
analysis of an esaD mutant strain [32] indicated that EsaD was an accessory 5 
factor required for the secretion of other Ess substrates. However, more 6 
recently it has been shown that EsaD is a large type VII-secreted anti-7 
bacterial toxin, with a nuclease domain at its C-terminus that targets the DNA 8 
of sensitive strains of S. aureus [31]. Two further ess-encoded proteins are 9 
essential for EsaD biogenesis. EsaG is an EsaD anti-toxin, which binds to the 10 
nuclease domain of EsaD, protecting the producing cell from self-intoxication. 11 
Introduction of EsaG into a sensitive S. aureus strain offers significant 12 
protection against EsaD-mediated killing. A second protein, EsaE, binds to the 13 
non-nuclease part of EsaD and appears to target the EsaDG complex to the 14 
secretion machinery [31], analogous to the chaperone EspG that interacts 15 
with large PE/PPE substrate proteins in pathogenic mycobacteria [55, 56]. 16 
EsaG is probably stripped from EsaD during secretion as it is not detected in 17 
the supernatant, although co-secretion of EsaE with EsaD has been noted 18 
[31]. 19 
 20 
EsxB, EsxC and EsxD are all small secretion substrates, around 100 amino 21 
acids in length, but only EsxB belongs to the WXG100 family [38, 40, 43]. The 22 
functions of these proteins are not clear. The genes encoding EsxB and EsxC 23 
are required for virulence in a mouse abscess model. However, as deletion of 24 
 12 
these genes affects secretion and/or stability of other substrates, it is not clear 1 
whether their requirement for virulence is direct or indirect [40, 43].  2 
 3 
Analysis of 153 S. aureus genome sequences revealed that the ess locus falls 4 
into four distinct clusters [45], three of which do not encode EsxB, EsxC, EsxD 5 
or EsaD. Instead, each of these has a distinct set of genes downstream of the 6 
core ess genes, indicative of discrete repertoires of substrates. The complete 7 
repertoire of Ess-secretion substrates in the S. aureus pan-genome remains 8 
to be elucidated, but it is likely that substrates will include further antibacterial 9 
toxins and proteins that contribute to virulence. 10 
 11 
Type VII secretion in Bacillus  12 
Type VII systems are present in both pathogenic and non-pathogenic species 13 
of Bacillus. In the model organism B. subtilis, the core functional components 14 
of an ESX secretion system are encoded by the yuk/yue locus that contains 15 
yukE, yukD, yukC, yukBA, yueB and yueC (Figure 1) [57, 58]. YukBA is an 16 
FtsK/SpoIIIE family ATPase that mediates the export of YukE, a member of 17 
the WXG100 protein superfamily. YukE secretion and stability is dependent 18 
on phosphorylated DegU, the response regulator of the DegU-DegP two 19 
component system [57]. YukD is a small ubiquitin-like protein with a very short 20 
C-terminal tail [46]. YukD is homologous to the S. aureus EsaB, which is 21 
essential for secretion in some S. aureus strains [41, 43], while YukC is 22 
similar to the S. aureus structural protein EssB [59]. YueB is a surface protein 23 
that has been reported to accumulate at the bacterial poles, as observed for 24 
the mycobacterial ESX-1 proteins [60, 61]. YueB is essential for phage SPP1 25 
 13 
binding and the yuk operon, particularly YukE, contributes to phage infection 1 
[59]. Recently, YueB was also implicated in conjugative DNA transfer [62].  2 
 3 
Interestingly, unlike other type VII systems, YukE appears to be the only 4 
substrate associated with the Bacillus system. Although a second potential 5 
WXG100 substrate YfjA was identified in B. subtilis genome [10], there is no 6 
evidence that the associated protein is exported in a YukBA-dependent 7 
fashion [57, 58]. Utilizing this simple Bacillus system Sysoeva et al [35] 8 
demonstrated that YukE was secreted as a homodimer, and that the WXG100 9 
motif and a C-terminal sequence are required for its secretion. Intriguingly, 10 
YukE was secreted as an intact dimeric complex and a bipartite signal formed 11 
by the two motifs, each contributed by individual subunits of the dimer, was 12 
required for its export [35]. As these motifs are typically present in type VII 13 
substrates, this novel mechanism of substrate recognition and protein 14 
translocation may be conserved across other type VII systems. 15 
 16 
 The ATPase domain requirements for substrate translocation in Bacillus were 17 
recently dissected in a study of domain-specific nucleotide binding and 18 
hydrolysis [63]. Only one of the three ATPase domains of YukBA was 19 
required for secretion in Bacillus, similar to that observed in ATPases from 20 
some S. aureus strains [40]. This is similar to the mycobacterial EccC 21 
ATPases such as the EccC5, where only ATP binding to the D1 domain is 22 
necessary for secretion [64], but in contrast to the mycobacterial split ATPase 23 
EccC1, where nucleotide binding is required at all three domains [6, 63].  24 
 25 
 14 
In the pathogen B. anthracis, six WXG100 proteins were discovered by 1 
genome analysis: EsxB, EsxL, EsxP, EsxQ, EsxV and EsxW (Figure 1) [65]. 2 
EsxB and EsxW have been detected from culture filtrates in vitro, while EsxW, 3 
EsxB and EsxP are expressed only during guinea pig infection [65]. It is 4 
possible that B. anthracis Esx substrates are induced only under specific yet-5 
to-be-identified conditions.  6 
 7 
As with S. aureus, an FtsK SpoIIIE-type ATPase, designated B. anthracis 8 
EssC is required for EsxB secretion. Deletion of EsxB specifically affected 9 
secretion of EsxW, and yeast-2-hybrid analysis showed that the two proteins 10 
interact, suggesting that EsxB is required for the stability and secretion of 11 
EsxW (although not the other way around) [65]. The crystal structure of EsxB 12 
revealed a helix-loop-helix hairpin, which allows the protein to associate into 13 
two distinct helical bundles [66]. This structural duality may enable formation 14 
of homo and hetero-oligomeric helix bundles with other Esx substrates, 15 
supporting the idea that EsxB could serve as an adaptor for secretion.  16 
 17 
Type VII Effectors and Host-Pathogen Interactions 18 
Type VII effectors from bacteria with intracellular lifestyles, particularly 19 
mycobacteria, are adept at modulating host cell pathways. T7SS substrates 20 
can interfere with or induce cellular functions in numerous ways, enabling the 21 
bacterium to survive within the host [15] (Figure 3, Table 2).  22 
 23 
Host Cell Modulation  24 
 15 
The ESX-1 locus was originally discovered because loss of the locus was 1 
associated with loss of virulence in the attenuated vaccine strain BCG [67]. 2 
ESX-1 effectors are required for the virulence of M. tuberculosis and impact 3 
on several host functions including apoptosis, necrosis, induction of 4 
interferons, cytolysis and granuloma formation [68-70]. EsxA directly interacts 5 
with host cell membranes causing host cell lysis and phagosomal rupture, 6 
which then results in the translocation of bacterial DNA and initiation of 7 
cytosolic surveillance pathways leading to ubiquitination, autophagy and 8 
interferon responses [71-73] (Figure 3).  9 
 10 
In the facultatively intracellular pathogen S. aureus, Ess is required for 11 
virulence and bacterial persistence during infection [40, 41, 43]. Interestingly, 12 
EsxA delays host cell apoptosis, and EsxA and EsxB together facilitate 13 
release of intracellular S. aureus from human epithelial cells [39]. While the 14 
cellular mechanisms underlying the modulation of cell death need further 15 
investigation and there are probably differences in the pathways targeted, it is 16 
intriguing that Esx proteins from two diverse pathogens, S. aureus and M. 17 
tuberculosis have been recruited to exploit the host cell as a niche for survival. 18 
By contrast, the ESAT-6 homologue, EsxA, from the intracellular pathogen, 19 
Listeria monocytogenes appears to play no role in intracellular survival or 20 
virulence [74]. Furthermore, a recent study reported that L. monocytogenes 21 
lacking EsxA demonstrated increased virulence, suggesting a detrimental 22 
effect of ESX-1 during infection [75]. 23 
 24 
Immune Modulation  25 
 16 
The effectors of ESX-1, ESX-3 and ESX-5 are potent activators of CD4+ and 1 
CD8+T cells [76-78]. Type VII effectors such as EsxA and EsxH have become 2 
prime anti-tuberculosis vaccine candidates because of their strong 3 
immunogenic properties [78]. Similarly, the EsxA and EsxB proteins from S. 4 
aureus are being considered as vaccine candidates because they induce a 5 
strong protective antibody response in murine infection models [79]. However, 6 
it is not clear whether staphylococcal Esx proteins induce cell-mediated 7 
immune responses. 8 
 9 
Bacterial Functions of Type VII Systems 10 
The conservation of the T7SS across diverse phyla indicates that these 11 
proteins may play important roles in bacteria. The type VII effectors have 12 
been associated with a number of fundamental bacterial pathways, in both 13 
pathogenic and non-pathogenic species (Table 2, Figure 3). 14 
 15 
DNA Transfer  16 
Soon after its discovery, ESX-1 was shown to be essential for conjugative 17 
DNA transfer in the environmental mycobacterium, Mycobacterium smegmatis 18 
[80, 81]. ESX-1 effectors are thought to influence DNA transfer by 19 
chaperoning proteins specific to donors or recipients, thereby inhibiting or 20 
promoting donor-recipient cell contact. Remarkably, ESX-1 was recently 21 
shown to encode a switch in mating identity from recipient to donor in 22 
transconjugants. The mating identity (mid) locus was mapped within the esx-1 23 
(Ms0069-0071 and Ms0076-0078) and was shown to have orthologs in other 24 
environmental mycobacteria [82]. ESX-1 may be required for DNA transfer 25 
 17 
simply because it mediates secretion of the Mid proteins which dictate the 1 
mating identity. In B. subtilis, YueB, is also known to play a role in conjugative 2 
transfer of the plasmid pLS20. However, the core T7SS ATPase, YukBA, was 3 
not directly involved in DNA transfer [62]. The mechanism of YueB-mediated 4 
plasmid transfer remains unknown. 5 
 6 
Metal Uptake  7 
The mycobacterial ESX-3 T7SS has been implicated in the uptake of metal 8 
ions [83, 84]. In M. smegmatis and M. tuberculosis, expression of ESX-3 9 
proteins is upregulated under iron- or zinc- depleted conditions. Although it is 10 
not clear precisely how ESX-3 effectors mediate iron uptake, they appear to 11 
influence uptake of mycobactins, molecules that bind iron, and deliver it to the 12 
mycobacterial cell [83]. ESX-3 was reported to be essential for growth in 13 
pathogenic mycobacteria, although a recent study suggests that these 14 
proteins are non-essential when iron is provided in an accessible form [85, 15 
86]. However, some ESX-3 substrates may have iron-independent functions 16 
in virulence [86]. It remains unclear whether type VII secretion plays a role in 17 
metal uptake in non-mycobacterial systems. 18 
 19 
Cell Envelope Integrity  20 
Recent work has indicated that the type VII effectors localise to the capsule of 21 
the fish pathogen Mycobacterium marinum [87]. ESX-1 and ESX-5 effectors 22 
also have an impact on the integrity of the mycobacterial capsule and the 23 
stability of the cell wall [88, 89]. These studies suggest that T7SS has a key 24 
function in bacterial cell envelope homeostasis, a fundamental requirement for 25 
 18 
bacterial survival. Such cell envelope maintenance functions have thus far 1 
been limited to mycobacteria. 2 
 3 
Sporulation and Development  4 
The type VII system of the plant pathogen Streptomyces scabies does not 5 
have a role in virulence, but rather surprisingly plays a role in development 6 
and sporulation [90]. Defective spore formation has also observed in T7SS 7 
effector mutants of the non-pathogenic Streptomyces coelicolor [91]. 8 
Interestingly, deletion of the ATPase (EccC) responsible for effector secretion 9 
does not produce similar phenotypes, suggesting an intracellular role for 10 
these effectors, perhaps in nucleoid restructuring, which could in turn 11 
influence the developmental programme [90]. Twinned with the role of Esx 12 
proteins in DNA transfer in mycobacteria, these observations suggest that 13 
regulation of DNA interactions may be a recurrent theme in type VII secretion. 14 
In B. subtilis, no sporulation defects have been reported for the yuk/yue 15 
deletion mutants. However, YukE is controlled by phosphorylation of DegU, a 16 
protein that accumulates in stationary phase and that has been associated 17 
with cell differentiation in bacterial populations [57, 92]. 18 
 19 
Interbacterial Competition   20 
As described earlier, the EsaD nuclease produced by S. aureus serves to kill 21 
competitor bacteria, while the cells producing the toxin produce antitoxins to 22 
protect themselves [31]. Over half of the S. aureus strains analysed encode 23 
EsaD, suggesting that it plays an important role in the ecology of this species. 24 
In addition, the sequence of the nuclease domain is highly polymorphic, 25 
 19 
consistent with a role in intra-species competition. S. aureus strains also 1 
accumulate esaG homologues in strains that do not encode esaD, suggesting 2 
a molecular arms race where strains accumulate anti-toxins to protect 3 
themselves from polymorphic EsaD variants [31]. Along with recent evidence 4 
from bioinformatics surveys, these observations suggest that interbacterial 5 
competition represents a function common to many T7SSs. It also highlights 6 
the parallels in versatility between type VI and type VII secretion, in that both 7 
systems are capable of targeting eukaryotes and bacteria. 8 
 9 
Concluding Remarks 10 
A decade or more after its discovery, type VII secretion represents a 11 
continuing, intriguing and important puzzle. Although there are meaningful 12 
homologies visible in the T7SS apparatus and effectors across huge 13 
phylogenetic distances, it has been hard to shoehorn their diverse features 14 
into a simple one-size-fits-all functional framework. They target membranes, 15 
proteins and DNA and have functions within and outside of the bacterial cell. 16 
They govern interactions between bacteria and their conspecific competitors, 17 
but also mediate host-pathogen interactions. They provide us with novel 18 
vaccine and drug targets, as well as new tools for diagnosis. In closing, it is 19 
worth stressing that much remains to be discovered (see Outstanding 20 
Questions), as so far we have characterised just a few of these systems in the 21 
laboratory. As bioinformatics surveys suggest, most of the vast landscape of 22 
type VII remains uncharted and untraveled.  23 
  24 
 20 
Figure Legends 1 
 2 
Figure 1. Distribution of WXG100 Domains, Key Components of Type VII 3 
Secretion. Genomic organization of the type VII secretion system clusters in 4 
selected species representative of Actinobacteria: M. tuberculosis & S. 5 
coelicor; Firmicutes: S. aureus, L. monocytogenes, S. agalactiae, B. subtilis & 6 
B. anthracis; Gammaproteobacteria: H. pylori. All genetic loci contain a 7 
member of the FtsK/SpoIIIE family (yellow) and at least one gene belonging to 8 
the WXG100 superfamily (red). Shown in blue are genes associated with 9 
toxin-antitoxin systems. Arrows represent direction of transcription and 10 
relative length of the genes. 11 
 12 
Figure 2. The Staphylococcal Type VII Secretion System, Ess. A model 13 
showing the core Ess secretion machinery, substrates and accessory 14 
proteins. Membrane-associated proteins (blue), substrates (yellow), 15 
cytoplasmic proteins (green) and FtsK/SpoIII ATPase (red) are shown. 16 
 17 
Figure 3. Biological Functions of T7SS. A model illustrating roles for T7SS 18 
in bacterial cellular functions, intra/inter-bacterial interactions and host-19 
bacterial interactions.20 
 21 
Table 1. Distribution of WXG100 proteins in Diverse Bacteriaa 
 
aThis tabulation draws on the taxonomic distribution of the WXG100 PFAM domain PF06013 
and on PSI-BLAST searches of the NCBI non-redundant sequence databases performed with 
the EsxA and Hp0062 sequences from M. tuberculosis and H. pylori. 
 
 
 
 
Phylum or 
Subphylum 
Species 
Bacteroidetes Bacteroides cellulosilyticus , Bacteroides 
intestinalis, Prevotella bryantii 
Chloroflexa Chloroflexus sp MS-G, Roseiflexus castenholzii 
Cyanobacteria Arthrospira, Arthrospira maxima, Arthrospira 
platensis, Arthrospira sp. TJSD091, 
Cyanobacterium aponinum, Geminocystis 
herdmanii, Leptolyngbya sp. PCC 7376, 
Lyngbya sp. PCC 8106, Pseudanabaena biceps 
Fusobacteria Fusobacterium periodonticum 
Lentisphaerae Lentisphaera araneosa 
Planctomycetes Gemmata obscuriglobus, Gemmata sp. IIL30, 
Gemmata sp. SH-PL17, Isosphaera pallida, 
Phycisphaera mikurensis, Phycisphaerae 
bacterium SM23_30, Pirellula sp. SH-Sr6A, 
Pirellula staleyi, Pirellula staleyi DSM 6068, 
Planctomyces sp. SH-PL14, Planctomyces sp. 
SH-PL62, Rhodopirellula baltica WH47, 
Rhodopirellula europaea 6C, Rhodopirellula 
islandica, Rhodopirellula maiorica, 
Rhodopirellula sallentina, Rhodopirellula sp. 
SWK7, Schlesneria paludicola, Singulisphaera 
acidiphila, Zavarzinella formosa 
-Proteobacteria  Acetobacter persici 
-Proteobacteria  Kingella denitrificans, Delftia acidovorans, 
Bordetella petrii 
-Proteobacteria  Desulfatibacillum aliphaticivorans 
-Proteobacteria  Helicobacter bizzozeronii, Helicobacter felis, 
Helicobacter heilmannii, Helicobacter trogontum, 
Sulfurimonas gotlandica 
-Proteobacteria  
 
Aeromonas bestiarum, Alcanivorax pacificus, 
Halomonas hydrothermalis, Methylomonas 
methanica, Pseudomonas aeruginosa, 
Pseudomonas lundensis, Pseudomonas 
stutzeri, Pseudomonas taeanensis, 
Pseudomonas veronii, Stenotrophomonas 
maltophilia, Vibrio cholerae, Vibrio halioticoli 
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Table 2. Summary of Type VII Effectors and Their Functionsa 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a Mycobacterial substrates EsxM, EsxN, EspB, EspC, EspE, EspF, EspJ, EspK, PE15, 
PPE20, PE35, PPE68, PE25 and PPE41, all of unknown function, have not been included in 
this table.* EspA does not play a role in cell wall integrity in all M. tuberculosis strains [95] 
 
 
  
Type VII 
Effectora 
Species Roles 
EsxA M. tuberculosis 
M. marinum 
Cell membrane lysis [2], activation of 
interferon responses [69], T-cell 
activation [76], induction of cell 
apoptosis [70], virulence [3, 4] 
M smegmatis DNA transfer [80] 
S. scabies 
S. coelicolor 
Spore formation [90, 91], cell 
development [91], 
phage resistance [90] 
S. aureus 
 
 
Modulation of host cell apoptosis [39], 
virulence [41, 43], protective antibody 
response [79] 
L. monocytogenes Unknown 
EsxB M. tuberculosis 
M. smegmatis 
Cell membrane lysis [2], virulence[3] 
S. scabies 
S. coelicolor 
Spore formation [90, 91], cell 
development [91], phage 
resistance [90] 
S. aureus 
 
Virulence [43], protective antibody 
response [79] 
B. anthracis Unknown 
EsxG M. tuberculosis Iron and zinc uptake [83, 84] 
M. smegmatis Iron uptake [83] 
EsxH M. tuberculosis 
 
Iron and zinc uptake [83], intracellular 
growth, phagosome maturation [93] T-
cell immunogen 
M. smegmatis Iron uptake [83] 
EspA M. tuberculosis Virulence, cell wall integrity* [88] 
PE19 M. tuberculosis Virulence, cell wall permeability [77, 
94] 
PE5 M. tuberculosis Iron uptake 
PPE4 M. tuberculosis Iron uptake 
PPE-10 M. marinum Capsule integrity [89] 
EsaD S. aureus Interbacterial competition [31] 
EsxC S. aureus Bacterial persistence [43] 
EsxD S. aureus Unknown 
YukE B. subtilis Unknown 
EsxP B. anthracis Unknown 
EsxW B. anthracis Unknown 
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Trends  
 
 T7SSs are more widespread among bacteria than previously thought; 
unlike other bacterial secretion systems, they are present across 
diverse bacterial phyla, in both Gram-positive and Gram-negative 
bacteria. 
 
 Non-mycobacterial T7SSs have distinct secretion machinery and 
mechanisms of secretion compared to their mycobacterial 
counterparts. 
 
 Bioinformatics surveys have highlighted an association between toxin-
antitoxin modules and type VII secretion in a number of bacterial 
species and a recent report provides experimental evidence of a role in 
intra-bacterial interactions in S. aureus. 
 
 Type VII effectors display a range of species-specific cellular functions,  
and can modulate interbacterial interactions as well as interactions 
between bacteria and eukaryotic cells. 
 
 
 
 
Trends Box
Outstanding Questions  
1. What is the structure of the T7SS apparatus? 
2. What role does the T7SS play in Gram-negative bacteria? Are 
substrates targeted to the periplasm or are they exported from the 
cell? If they leave the cell, how do they cross the outer membrane? 
3. Is there crosstalk between T7SSs and other secretion systems? 
4. Are there common functions for the T7SSs across pathogenic and 
environmental bacteria? 
5. How do the Esx toxin-antitoxin modules influence interactions within 
bacterial communities in the environment or during colonisation and 
infection? 
6. Which host proteins do Esx proteins interact with during intracellular 
infection?  
7. What is the role of staphylococcal T7SS effectors during persistent 
infection? 
 
 
Outstanding Questions
